Key facts
- Cellva’s last known valuation is $9.7M (Aug 2024).
- It has raised $6.7M; the latest was Later Stage VC ($3.8M) in Mar 2026.
- Notable investors include MassChallenge, AIR Capital, Digiboard, FEA Angels, Fundepar — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Cellva
- ·The full record, as it builds
Funding rounds
No funding rounds for Cellva are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cellva
Developer of a biotechnology platform designed to drive food innovation through microencapsulation and biofabrication. The company offers natural flavor carriers, reduced saturated fat alternatives, and bioactive compounds derived from Brazilian biodiversity, enabling food and nutraceutical manufacturers to access sustainable, functional ingredients with enhanced nutritional value and reduced environmental impact.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Sao Paulo, Brazil
- Founded
- 2021
- Employees
- 14
- Website
- cellva.com/
- Ownership
- Privately Held (backing)
Cellva doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cellva shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cellva in its N-PORT filings yet. We sweep new filings monthly.